Prudential plc’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.97M Sell
13,569
-3,705
-21% -$1.22M 0.02% 309
2025
Q4
$6.06M Sell
17,274
-2,888
-14% -$976K 0.05% 259
2025
Q3
$6.51M Sell
20,162
-11,848
-37% -$3.68M 0.05% 252
2025
Q2
$12.5M Sell
32,010
-4,795
-13% -$1.93M 0.08% 146
2025
Q1
$16M Sell
36,805
-17,661
-32% -$7.09M 0.08% 102
2024
Q4
$20.1M Sell
54,466
-1,122
-2% -$470K 0.1% 82
2024
Q3
$28.9M Buy
55,588
+22,738
+69% +$12.1M 0.15% 49
2024
Q2
$17.8M Buy
32,850
+1,571
+5% +$830K 0.12% 88
2024
Q1
$16.2M Buy
31,279
+15,062
+93% +$7.49M 0.12% 94
2023
Q4
$7.65M Sell
16,217
-2,659
-14% -$1.23M 0.08% 163
2023
Q3
$8.22M Sell
18,876
-1,674
-8% -$759K 0.09% 131
2023
Q2
$9.13M Buy
20,550
+877
+4% +$405K 0.11% 130
2023
Q1
$9.05M Sell
19,673
-21
-0.1% -$9.99K 0.11% 120
2022
Q4
$10.1M Buy
19,694
+6,559
+50% +$3.33M 0.13% 107
2022
Q3
$5.97M Buy
13,135
+522
+4% +$250K 0.09% 133
2022
Q2
$6.09M Buy
12,613
+544
+5% +$269K 0.11% 126
2022
Q1
$5.93M Buy
12,069
+5,955
+97% +$2.72M 0.09% 135
2021
Q4
$2.83M Buy
+6,114
New +$2.57M 0.04% 213
2020
Q3
Sell
-155,600
Closed -$40.9M 613
2020
Q2
$40.9M Sell
155,600
-79,250
-34% -$21.1M 0.2% 152
2020
Q1
$53.3M Sell
234,850
-105,950
-31% -$28.9M 0.28% 121
2019
Q4
$103M Sell
340,800
-503,296
-60% -$138M 0.43% 76
2019
Q3
$203M Buy
844,096
+22,798
+3% +$6.25M 0.6% 43
2019
Q2
$232M Buy
821,298
+426,668
+108% +$117M 0.71% 33
2019
Q1
$113M Buy
394,630
+14,643
+4% +$4.23M 0.41% 77
2018
Q4
$99.8M Sell
379,987
-10,218
-3% -$2.81M 0.4% 75
2018
Q3
$107M Sell
390,205
-14,532
-4% -$3.77M 0.35% 86
2018
Q2
$96.3M Buy
404,737
+7,351
+2% +$1.7M 0.3% 102
2018
Q1
$87.3M Sell
397,386
-33,092
-8% -$7.77M 0.27% 105
2017
Q4
$96.9M Buy
430,478
+1,485
+0.3% +$316K 0.3% 103
2017
Q3
$81.5M Sell
428,993
-2,247
-0.5% -$428K 0.26% 113
2017
Q2
$81.1M Sell
431,240
-12,055
-3% -$2.17M 0.27% 112
2017
Q1
$73.3M Sell
443,295
-121,100
-21% -$19.3M 0.25% 119
2016
Q4
$81.1M Buy
564,395
+242,200
+75% +$32.4M 0.29% 107
2016
Q3
$40.4M Buy
322,195
+6,609
+2% +$853K 0.15% 156
2016
Q2
$41.4M Buy
315,586
+8,233
+3% +$1.13M 0.16% 153
2016
Q1
$42.7M Sell
307,353
-1,906
-0.6% -$255K 0.17% 146
2015
Q4
$43.1M Buy
309,259
+12,618
+4% +$1.74M 0.18% 138
2015
Q3
$41.5M Buy
296,641
+26,438
+10% +$3.97M 0.18% 132
2015
Q2
$44.4M Buy
270,203
+65,772
+32% +$10.5M 0.17% 142
2015
Q1
$31.6M Sell
204,431
-10,862
-5% -$1.55M 0.14% 165
2014
Q4
$27.1M Sell
215,293
-10,031
-4% -$1.24M 0.11% 176
2014
Q3
$27M Sell
225,324
-91,781
-29% -$10.5M 0.11% 173
2014
Q2
$34.1M Buy
317,105
+13,897
+5% +$1.43M 0.14% 158
2014
Q1
$30.2M Sell
303,208
-81,875
-21% -$7.4M 0.13% 151
2013
Q4
$35.6M Buy
385,083
+104,657
+37% +$9.3M 0.15% 152
2013
Q3
$23.4M Buy
280,426
+242,706
+643% +$20.8M 0.12% 170
2013
Q2
$3.09M Buy
+37,720
New +$2.82M 0.02% 309

Other funds holding ELV

Prudential plc's ELV Position: Q1 2026 in Review

Prudential plc reduced its Elevance Health (ELV) stake by 21% in Q1 2026, selling an estimated $1.22M and leaving 13,569 shares worth $3.97M. The position accounts for 0.02% of the portfolio, ranked #309.

Prudential plc first reported a position in ELV in Q2 2013 and has held it in 47 quarters since. The position peaked at $232M in Q2 2019. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Prudential plc held 13,569 shares of Elevance Health worth $3.97M as of Q1 2026.
  • Prudential plc sold 3,705 Elevance Health shares in Q1 2026, an estimated $1.22M.
  • Elevance Health made up 0.02% of Prudential plc's portfolio in Q1 2026, its #309 holding.
  • Prudential plc first reported a position in Elevance Health in Q2 2013 and has held it in 47 quarters since.
  • Prudential plc's Elevance Health position peaked at $232M in Q2 2019.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Prudential plc's 13F filing for Q1 2026, filed 14 May 2026.